Monitor for follow-up active manager participation — if active funds begin buying, this could confirm a broader shift in sentiment. Also watch for trading volume and float concentration changes that could drive price momentum.
Executive Summary
Three major passive institutions — Morgan Stanley, Wells Fargo, and UBS — significantly increased their positions in CG Oncology (CGON) during Q4 2024, collectively adding $37.8M in new exposure with UBS driving the largest increase. This coordinated accumulation by mega-passive funds suggests strong institutional interest, potentially driven by index inclusion or sector reallocation. Despite the bullish cluster, the activity is concentrated in passive managers, which may reflect mechanical rebalancing rather than active conviction.
Key Financial Metrics
Institutional Positions
Net institutional flow: $37.8M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +208.8% | $20.8M | $11.9M |
| Wells Fargo | ADD | +45.3% | $810.0K | $77.0K |
| UBS | DOUBLED | +1071.7% | $29.1M | $25.8M |
Key Facts
- Morgan Stanley doubled its position, increasing value by $11.9M to $20.8M
- UBS increased its stake by over 1000%, adding $25.8M in value to reach $29.1M
- Wells Fargo added $77K in value, increasing holdings by 45.3%
- No institutional selling was detected in this quarter
Financial Impact
3 institutions accumulated $37.8M in net new positions, bringing total current holdings to $50.7M
Risk Factors
- Activity dominated by passive investors, suggesting rebalancing rather than fundamental conviction
- Lack of active manager participation may limit upside catalyst potential
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CGON-2024-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | Press Release | $74.85 $74.33 | ▲ +0.69% | ▲ +1.29% | — |
Aug 6, 2026 8w ago | 424B5 | $74.85 $74.33 | ▲ +0.69% | ▲ +1.29% | — |
Jul 27, 2026 9w ago | Press Release | $72.62 $78.95 | ▲ +8.72% | ▲ +5.34% | — |
Jul 17, 2026 11w ago | Insider Cluster | $71.85 $75.03 | ▲ +4.43% | ▼ −0.02% | — |
Jul 16, 2026 11w ago | Court Ruling | $69.50 $74.71 | ▲ +7.50% | ▲ +3.88% | — |
Jun 24, 2026 14w ago | 144 | $72.84 $71.12 | ▼ −2.36% | ▼ −2.89% | — |
Jun 22, 2026 14w ago | 144 | $65.73 $70.19 | ▲ +6.79% | ▲ +5.63% | — |
Jun 12, 2026 16w ago | Institutional Cluster | $59.56 $75.24 | ▲ +26.33% | ▲ +24.55% | — |
May 26, 2026 18w ago | 8-K | $61.89 $70.25 | ▲ +13.50% | ▲ +15.45% | — |
May 15, 2026 20w ago | Press Release | $66.93 $59.56 | ▼ −11.01% | ▼ −13.13% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access